Dr. Zuhayr Adia currently serves as the Regional Patient Care Partner at BIOCODEX, where responsibilities include stakeholder engagement, medical affairs, and evidence generation within the Rare Epileptic Encephalopathies field. Prior roles include Management Consultant at Clarivate, focusing on commercial strategy and market access in pharmaceuticals, and management consulting positions at Chequers Health Group and BiteLabs Healthtech. Dr. Adia is the founder and former CEO of Neuraleaf Biopharmaceuticals Ltd. Educational qualifications include a Bachelor of Medicine, Bachelor of Surgery (MBBS) and a BSc in Healthcare Management from King's College London.